Most Genetic Risk for Drug Abuse Is Shared Across Substances, Not Drug-Specific
A large Swedish twin and sibling study found that 75-90% of genetic risk for cannabis, stimulant, and sedative abuse comes from a shared vulnerability to substance use in general, not from drug-specific genes.
Quick Facts
What This Study Found
Researchers analyzed registry data from nearly 80,000 Swedish male twin and sibling pairs to understand whether genetic risk for drug abuse is substance-specific or shared across drug types.
The total heritability for cannabis, stimulant, and sedative abuse ranged from 64-70%. Of that genetic risk, 75-90% was non-specific, meaning the same genetic factors influenced vulnerability to all three substance types.
All shared environmental effects (18-20% of variance) were also non-specific. This suggests that genetic variation at the specific brain sites where each drug acts plays a surprisingly minor role in who develops substance abuse problems.
Key Numbers
Total heritability: 64-70% across substance types; 75-90% of genetic risk was non-specific; shared environment accounted for 18-20% of variance; 76,457 sibling pairs and 2,939 twin pairs analyzed
How They Did This
Population-based study using Swedish national registries. Included 1,720 monozygotic twin pairs, 1,219 dizygotic twin pairs, and 76,457 near-age full sibling pairs. Substance abuse was identified through objective registry records rather than self-report. Structural equation modeling compared common pathway and independent pathway models.
Why This Research Matters
This confirms with objective data what interview-based studies suggested: the genetic architecture of drug abuse is mostly about general vulnerability rather than specific attraction to particular substances. This has implications for both prevention and treatment approaches.
The Bigger Picture
If most genetic risk for substance abuse is shared across drug classes, then the biological pathways driving addiction likely involve general reward processing, impulsivity, or stress response rather than drug-specific receptor variations.
What This Study Doesn't Tell Us
Male-only sample limits generalizability to women. Registry-based ascertainment may miss less severe cases. The study examined abuse rather than use, so findings may not apply to casual or recreational patterns.
Questions This Raises
- ?What specific biological pathways account for the shared genetic risk?
- ?Would women show the same pattern of non-specific genetic vulnerability?
- ?How do the substance-specific genetic factors that do exist differ across drug classes?
Trust & Context
- Key Stat:
- 75-90% of genetic risk for drug abuse is shared, not substance-specific
- Evidence Grade:
- Very large population-based twin/sibling design with objective registry data, though cross-sectional and limited to males.
- Study Age:
- Published in 2015 using Swedish registry data. The genetic architecture of substance abuse is unlikely to have changed.
- Original Title:
- A population-based Swedish Twin and Sibling Study of cannabis, stimulant and sedative abuse in men.
- Published In:
- Drug and alcohol dependence, 149, 49-54 (2015)
- Authors:
- Kendler, Kenneth S(7), Ohlsson, Henrik, Maes, Hermine H(3), Sundquist, Kristina, Lichtenstein, Paul, Sundquist, Jan
- Database ID:
- RTHC-00989
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Does this mean addiction is genetic?
Genetics account for 64-70% of the variation in substance abuse risk, but environment still plays a significant role (18-20% from shared environment, plus non-shared environmental factors).
If genetic risk is shared, why do people prefer different drugs?
A smaller portion (10-25%) of genetic risk is substance-specific, and environmental factors like availability, peer influence, and cultural context strongly shape which substances people encounter and use.
Read More on RethinkTHC
- cannabis-cardiovascular-heart-risk-stroke
- cannabis-heart-cardiovascular-risk
- coughing-up-stuff-after-quitting-weed
- lung-recovery-after-quitting-smoking-weed
- lung-recovery-quitting-weed
- quitting-weed-female-hormones
- quitting-weed-weight-gain-loss-diet-appetite
- sex-after-quitting-weed
- weed-DUI-driving-impaired-cannabis-laws
- weed-acne-skin
- weed-fertility-sperm
- weed-gut-digestion-problems
- weed-heart-health
- weed-testosterone-levels
Cite This Study
https://rethinkthc.com/research/RTHC-00989APA
Kendler, Kenneth S; Ohlsson, Henrik; Maes, Hermine H; Sundquist, Kristina; Lichtenstein, Paul; Sundquist, Jan. (2015). A population-based Swedish Twin and Sibling Study of cannabis, stimulant and sedative abuse in men.. Drug and alcohol dependence, 149, 49-54. https://doi.org/10.1016/j.drugalcdep.2015.01.016
MLA
Kendler, Kenneth S, et al. "A population-based Swedish Twin and Sibling Study of cannabis, stimulant and sedative abuse in men.." Drug and alcohol dependence, 2015. https://doi.org/10.1016/j.drugalcdep.2015.01.016
RethinkTHC
RethinkTHC Research Database. "A population-based Swedish Twin and Sibling Study of cannabi..." RTHC-00989. Retrieved from https://rethinkthc.com/research/kendler-2015-a-populationbased-swedish-twin
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.